NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting
Three-year data from NeuroPace’s Post-Approval Study of the RNS® System in drug-resistant focal epilepsy to be shared in oral presentationMOUNTAIN VIEW, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- ...
Boomers face a 'devastating' blow to their life savings as more tariff pain looms, finance guru warns
Finance professor Peter Ricchiuti told BI tariffs are "prosperity killers" that have turned running a business into a "big ...
Enliven Therapeutics Announces Poster Presentations at the 2025 AACR Annual Meeting
Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the ...